Transdermal delivery of insulin from poloxamer gel: ex vivo and in vivo skin permeation studies in rat using iontophoresis and chemical enhancers.
暂无分享,去创建一个
[1] J. Bouwstra,et al. Modes of action of terpene penetration enhancers in human skin; Differential scanning calorimetry, small-angle X-ray diffraction and enhancer uptake studies , 1996 .
[2] Russell O. Potts,et al. Evidence that Oleic Acid Exists in a Separate Phase Within Stratum Corneum Lipids , 1991, Pharmaceutical Research.
[3] R. Guy,et al. In vitro and in vivo iontophoresis of a tripeptide across nude rat skin , 1992 .
[4] Adrian C. Williams,et al. Terpenes and the Lipid–Protein–Partitioning Theory of Skin Penetration Enhancement , 2004, Pharmaceutical Research.
[5] B. Testa,et al. The skin as a drug-metabolizing organ. , 1978, Drug metabolism reviews.
[6] R. Bronaugh,et al. Determination of percutaneous absorption by in vitro techniques , 2001, Percutaneous Absorption.
[7] W. Ritschel,et al. Percutaneous absorption of rosmarinic acid in the rat. , 1989, Methods and findings in experimental and clinical pharmacology.
[8] S. C. Miller,et al. In vitro release of nicotinic acid alkyl esters from poloxamer vehicles , 1990 .
[9] J. Trimmer,et al. Transdermal delivery of human insulin to albino rabbits using electrical current. , 1989, The American journal of the medical sciences.
[10] L. John,et al. Blood glucose control in diabetic rats by transdermal iontophoretic delivery of insulin , 1988 .
[11] R Panchagnula,et al. Transdermal iontophoresis revisited. , 2000, Current opinion in chemical biology.
[12] J. Hadgraft,et al. Topical Application of Penetration Enhancers to the Skin of Nude Mice: a Histopathological Study , 1989, The Journal of pharmacy and pharmacology.
[13] O. Pillai,et al. Transdermal iontophoresis of insulin: IV. Influence of chemical enhancers. , 2004, International journal of pharmaceutics.
[14] K. Shung,et al. Hydrogels with enhanced mass transfer for transdermal drug delivery. , 1996, Journal of pharmaceutical sciences.
[15] R Panchagnula,et al. Transdermal iontophoresis. Part II: Peptide and protein delivery. , 1999, Methods and findings in experimental and clinical pharmacology.
[16] R. Reid. Peptide and Protein Drug Analysis , 1999 .
[17] B. Kári. Control of Blood Glucose Levels in Alloxan-diabetic Rabbits by Iontophoresis of Insulin , 1986, Diabetes.
[18] B. W. Barry. Lipid-Protein-Partitioning theory of skin penetration enhancement , 1991 .
[19] A. Kibbe. Handbook of Pharmaceutical Excipients , 2003 .
[20] B. Magnusson,et al. Terpenes and ethanol enhance the transdermal permeation of the tripeptide thyrotropin releasing hormone in human epidermis , 1997 .
[21] R Panchagnula,et al. Transdermal iontophoresis. Part I: Basic principles and considerations. , 1999, Methods and findings in experimental and clinical pharmacology.
[22] V. Lee,et al. Trends and Future Perspectives in Peptide and Protein Drug Delivery , 1995 .
[23] Pharmacokinetic‐pharmacodynamic modelling of human insulin: validity of pharmacological availability as a substitute for extent of bioavailability , 2001, The Journal of pharmacy and pharmacology.
[24] H. Junginger,et al. In Vitro Human Skin Barrier Modulation by Fatty Acids: Skin Permeation and Thermal Analysis Studies , 2004, Pharmaceutical Research.
[25] O. Pillai,et al. Insulin therapies - past, present and future. , 2001, Drug discovery today.
[26] M. Singh,et al. Structure-activity relationship of chemical penetration enhancers in transdermal drug delivery. , 2000, Current medicinal chemistry.
[27] T. Freeman,et al. Effect of penetration enhancers and iontophoresis on the ultrastructure and cholecystokinin-8 permeability through porcine skin. , 1997, Journal of pharmaceutical sciences.
[28] S. Mallapragada,et al. Understanding drug release from poly(ethylene oxide)-b-poly(propylene oxide)-b-poly(ethylene oxide) gels. , 2001, Journal of controlled release : official journal of the Controlled Release Society.
[29] Mandip Singh,et al. Skin permeation enhancement effect and skin irritation of saturated fatty alcohols. , 2002, International journal of pharmaceutics.
[30] Yie W. Chien,et al. Hydrogel-Based lontotherapeutic Delivery Devices for Transdermal Delivery of Peptide/Protein Drugs , 1993, Pharmaceutical Research.
[31] Y. Chien,et al. Facilitated transdermal transport of insulin. , 1987, Journal of pharmaceutical sciences.
[32] Howard I. Maibach,et al. Percutaneous Absorption: Drugs, Cosmetics, Mechanisms, Methods, Fourth Edition , 2005 .
[33] J. M. Marchetti,et al. Influence of lecithin on some physical chemical properties of poloxamer gels: rheological, microscopic and in vitro permeation studies. , 1999, International journal of pharmaceutics.
[34] B. Aungst. Structure/Effect Studies of Fatty Acid Isomers as Skin Penetration Enhancers and Skin Irritants , 1989, Pharmaceutical Research.
[35] C. Zakzewski,et al. Transdermal delivery of regular insulin to chronic diabetic rats: effect of skin preparation and electrical enhancement. , 1998, Journal of controlled release : official journal of the Controlled Release Society.
[36] O. Pillai,et al. Transdermal iontophoresis of insulin. V. Effect of terpenes. , 2003, Journal of controlled release : official journal of the Controlled Release Society.
[37] S. Mallapragada,et al. Experimental investigation and mathematical modeling of Pluronic F127 gel dissolution: drug release in stirred systems. , 2000, Journal of controlled release : official journal of the Controlled Release Society.
[38] Y. Kalia,et al. Transdermal drug delivery: overcoming the skin's barrier function. , 2000, Pharmaceutical science & technology today.
[39] T. Johnston,et al. Sustained-release interleukin-2 following intramuscular injection in rats , 1995 .
[40] Makoto Haga,et al. Transdermal iontophoretic delivery of insulin using a photoetched microdevice , 1997 .
[41] P. Elias,et al. Structural and functional effects of oleic acid and iontophoresis on hairless mouse stratum corneum. , 2000, The Journal of investigative dermatology.
[42] S. Bolton,et al. Effect of chemical enhancers and conducting gels on iontophoretic transdermal delivery of cromolyn sodium , 1994 .
[43] S. Ramanathan,et al. The use of chitosan gels as matrices for electrically-modulated drug delivery. , 2001, Journal of controlled release : official journal of the Controlled Release Society.
[44] T. Johnston,et al. Biological activity of urease formulated in poloxamer 407 after intraperitoneal injection in the rat. , 1992, Journal of pharmaceutical sciences.
[45] P. Ramarao,et al. Transdermal iontophoretic delivery of bovine insulin and monomeric human insulin analogue. , 1999, Journal of controlled release : official journal of the Controlled Release Society.
[46] Adrian C. Williams,et al. The enhancement index concept applied to terpene penetration enhancers for human skin and model lipophilic (oestradiol) and hydrophilic (5-fluorouracil) drugs , 1991 .
[47] J. Hadgraft,et al. Pharmaceutical skin penetration enhancement , 1993 .
[48] Seung Hun Lee,et al. The Pretreatment Effect of Chemical Skin Penetration Enhancers in Transdermal Drug Delivery Using Iontophoresis , 1999, Skin Pharmacology and Physiology.
[49] Tsutomu Suzuki,et al. Chitosan Capsules for Colon-Specific Drug Delivery: Improvement of Insulin Absorption from the Rat Colon , 1997 .
[50] W. Shi,et al. Transdermal Iontophoretic Delivery of Therapeutic Peptides/Proteins I: Insulin , 1987, Annals of the New York Academy of Sciences.
[51] A. Banga,et al. Systemic delivery of therapeutic peptides and proteins , 1988 .
[52] L. Saccá,et al. Direct assessment of splanchnic uptake and metabolic effects of human and porcine insulin. , 1984, The Journal of clinical endocrinology and metabolism.
[53] T. Nagai,et al. Iontophoretic transdermal absorption of insulin and calcitonin in rats with newly-devised switching technique and addition of urea , 1997 .